Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 14/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 13/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21318448 | 1.00 | CYP3A4 (0.47) | CYP3A4CYP2D6FGFR1ATM | |
| SCHEMBL15633560 | 0.96 | CYP3A4 (0.51) | CYP3A4CYP2D6FGFR1 | |
| SCHEMBL15633489 | 0.96 | CYP3A4 (0.51) | CYP3A4CYP2D6FGFR1 | |
| SCHEMBL15634070 | 0.96 | CYP3A4 (0.51) | CYP3A4CYP2D6FGFR1 | |
| SCHEMBL15633919 | 0.96 | CYP3A4 (0.51) | CYP3A4CYP2D6FGFR1 | |
| SCHEMBL15633881 | 0.96 | CYP3A4 (0.51) | CYP3A4CYP2D6FGFR1 | |
| SCHEMBL21318454 | 0.93 | CYP3A4 (0.53) | CYP3A4CYP2D6FGFR1 | |
| SCHEMBL21318447 | 0.92 | CYP3A4 (0.54) | CYP3A4CYP2D6FGFR1 | |
| SCHEMBL2547442 | 0.85 | CYP3A4 (0.47) | CYP3A4CYP2D6ATM | |
| SCHEMBL15633920 | 0.84 | CYP3A4 (0.51) | CYP3A4CYP2D6FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919922-B2 | Broad spectrum antiviral compounds | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2021-02-16 | — | — | US | disclosed |
| US-20190270762-A1 | NOVEL BROAD SPECTRUM ANTIVIRAL COMPOUNDS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2019-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919922-B2 | Broad spectrum antiviral compounds | ABL1, TH, SLC7A1 | CYP3A4 79/4885CYP2D6 92/4885FGFR1 464/4885 |
| US-20190270762-A1 | NOVEL BROAD SPECTRUM ANTIVIRAL COMPOUNDS | ZC3HAV1, ZC3HAV1L, EIF2AK2 | CYP3A4 2087/4885CYP2D6 1774/4885FGFR1 4260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.